Two Oklahoma Republican lawmakers are urging their colleagues to override Gov. Kevin Stitt’s (R) veto of a 340B contract pharmacy [...] …
Category: Pharma Industry
Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...] …
A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...] …
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...] …
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...] …
The California Assembly yesterday approved a bill to prohibit manufacturers from placing 340B contract pharmacy restrictions on grantee covered entities, [...] …
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...] …
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...] …